Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Research Report 2023

Hepatitis B is a viral infection caused due to transmission of the virus through contact with the blood or other body fluids of an infected person. It is considered as a serious occupational hazard for healthcare professionals, which affects the liver, causing acute and chronic diseases. Hence, Chinese hamster ovary cell (CHO) hepatitis B vaccine is considered to be the safe and effective method to prevent the hepatitis B infection. The major factor that fuels the growth of the market are increase in prevalence of hepatitis B infection worldwide. For example, approximately 887,000 deaths due to hepatitis B infection were recorded in 2015 across the globe. However, inherent disadvantages of using recombinant Chinese hamster ovary cell (CHO) to design hepatitis B vaccines restrains the growth of the market. Conversely, increase in government focus to promote (CHO) hepatitis B vaccination for adults and extensive research carried out for the same are expected to offer lucrative opportunities for the market.

The global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine include Merck & Co., Inc., GlaxoSmithKline Plc, Pfizer Inc., Sanofi Pasteur, CSL Limited, Emergent Biosolutions, Serum Institute of India and Johnson & Johnson, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine.

The Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

1.1 Product Overview and Scope of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine

1.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Segment by Type

1.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Value Comparison by Type (2023-2029)

1.2.2 Pediatric Hepatitis B (CHO) Vaccine

1.2.3 Adult Hepatitis B (CHO) Vaccine

1.3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Segment by Application

1.3.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Value by Application: (2023-2029)

1.3.2 Hospitals

1.3.3 Clinics

1.4 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Estimates and Forecasts

1.4.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue 2018-2029

1.4.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales 2018-2029

1.4.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Manufacturers (2018-2023)

2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Average Price by Manufacturers (2018-2023)

2.4 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine, Product Type & Application

2.7 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Competitive Situation and Trends

2.7.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Players Market Share by Revenue

2.7.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region: 2018-2029

3.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region: 2018-2023

3.2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region: 2024-2029

3.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region: 2018-2029

3.3.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region: 2018-2023

3.3.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region: 2024-2029

3.4 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Facts & Figures by Country

3.4.1 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2018-2029)

3.4.3 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2018-2029)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Facts & Figures by Country

3.5.1 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2018-2029)

3.5.3 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Facts & Figures by Country

3.6.1 Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2018-2029)

3.6.3 Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Facts & Figures by Country

3.7.1 Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2018-2029)

3.7.3 Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2018-2029)

3.8.3 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2018-2029)

4.1.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2018-2023)

4.1.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2024-2029)

4.1.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Type (2018-2029)

4.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type (2018-2029)

4.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type (2018-2023)

4.2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type (2024-2029)

4.2.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Type (2018-2029)

4.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Type (2018-2029)

5.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2018-2029)

5.1.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2018-2023)

5.1.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2024-2029)

5.1.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Application (2018-2029)

5.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2018-2029)

5.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2018-2023)

5.2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2024-2029)

5.2.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Application (2018-2029)

5.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Application (2018-2029)

6.1 Merck & Co., Inc.

6.1.1 Merck & Co., Inc. Corporation Information

6.1.2 Merck & Co., Inc. Description and Business Overview

6.1.3 Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio

6.1.5 Merck & Co., Inc. Recent Developments/Updates

6.2 GlaxoSmithKline Plc

6.2.1 GlaxoSmithKline Plc Corporation Information

6.2.2 GlaxoSmithKline Plc Description and Business Overview

6.2.3 GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.2.4 GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio

6.2.5 GlaxoSmithKline Plc Recent Developments/Updates

6.3 Pfizer Inc.

6.3.1 Pfizer Inc. Corporation Information

6.3.2 Pfizer Inc. Description and Business Overview

6.3.3 Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio

6.3.5 Pfizer Inc. Recent Developments/Updates

6.4 Sanofi Pasteur

6.4.1 Sanofi Pasteur Corporation Information

6.4.2 Sanofi Pasteur Description and Business Overview

6.4.3 Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio

6.4.5 Sanofi Pasteur Recent Developments/Updates

6.5 CSL Limited

6.5.1 CSL Limited Corporation Information

6.5.2 CSL Limited Description and Business Overview

6.5.3 CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.5.4 CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio

6.5.5 CSL Limited Recent Developments/Updates

6.6 Emergent Biosolutions

6.6.1 Emergent Biosolutions Corporation Information

6.6.2 Emergent Biosolutions Description and Business Overview

6.6.3 Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio

6.6.5 Emergent Biosolutions Recent Developments/Updates

6.7 Serum Institute of India

6.6.1 Serum Institute of India Corporation Information

6.6.2 Serum Institute of India Description and Business Overview

6.6.3 Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio

6.7.5 Serum Institute of India Recent Developments/Updates

6.8 Johnson & Johnson

6.8.1 Johnson & Johnson Corporation Information

6.8.2 Johnson & Johnson Description and Business Overview

6.8.3 Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.8.4 Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio

6.8.5 Johnson & Johnson Recent Developments/Updates

7.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Chain Analysis

7.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Mode & Process

7.4 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Marketing

7.4.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Channels

7.4.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Distributors

7.5 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Customers

8.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Trends

8.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Drivers

8.3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Challenges

8.4 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses) of Key Manufacturers (2018-2023)

    Table 5. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Average Price (USD/Dose) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine, Product Type & Application

    Table 12. Global Key Manufacturers of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region (2018-2023) & (K Doses)

    Table 18. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Region (2018-2023)

    Table 19. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region (2024-2029) & (K Doses)

    Table 20. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Region (2024-2029)

    Table 21. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Region (2018-2023)

    Table 23. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Region (2024-2029)

    Table 25. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2018-2023) & (K Doses)

    Table 27. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2024-2029) & (K Doses)

    Table 28. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2018-2023) & (K Doses)

    Table 32. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2024-2029) & (K Doses)

    Table 33. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region (2018-2023) & (K Doses)

    Table 37. Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region (2024-2029) & (K Doses)

    Table 38. Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2018-2023) & (K Doses)

    Table 42. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2024-2029) & (K Doses)

    Table 43. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2018-2023) & (K Doses)

    Table 47. Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2024-2029) & (K Doses)

    Table 48. Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses) by Type (2018-2023)

    Table 51. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses) by Type (2024-2029)

    Table 52. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Type (2018-2023)

    Table 53. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Type (2024-2029)

    Table 54. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Type (2018-2023)

    Table 57. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Type (2024-2029)

    Table 58. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price (USD/Dose) by Type (2018-2023)

    Table 59. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price (USD/Dose) by Type (2024-2029)

    Table 60. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses) by Application (2018-2023)

    Table 61. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses) by Application (2024-2029)

    Table 62. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Application (2018-2023)

    Table 63. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Application (2024-2029)

    Table 64. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Application (2018-2023)

    Table 67. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Application (2024-2029)

    Table 68. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price (USD/Dose) by Application (2018-2023)

    Table 69. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price (USD/Dose) by Application (2024-2029)

    Table 70. Merck & Co., Inc. Corporation Information

    Table 71. Merck & Co., Inc. Description and Business Overview

    Table 72. Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)

    Table 73. Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product

    Table 74. Merck & Co., Inc. Recent Developments/Updates

    Table 75. GlaxoSmithKline Plc Corporation Information

    Table 76. GlaxoSmithKline Plc Description and Business Overview

    Table 77. GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)

    Table 78. GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product

    Table 79. GlaxoSmithKline Plc Recent Developments/Updates

    Table 80. Pfizer Inc. Corporation Information

    Table 81. Pfizer Inc. Description and Business Overview

    Table 82. Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)

    Table 83. Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product

    Table 84. Pfizer Inc. Recent Developments/Updates

    Table 85. Sanofi Pasteur Corporation Information

    Table 86. Sanofi Pasteur Description and Business Overview

    Table 87. Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)

    Table 88. Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product

    Table 89. Sanofi Pasteur Recent Developments/Updates

    Table 90. CSL Limited Corporation Information

    Table 91. CSL Limited Description and Business Overview

    Table 92. CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)

    Table 93. CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product

    Table 94. CSL Limited Recent Developments/Updates

    Table 95. Emergent Biosolutions Corporation Information

    Table 96. Emergent Biosolutions Description and Business Overview

    Table 97. Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)

    Table 98. Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product

    Table 99. Emergent Biosolutions Recent Developments/Updates

    Table 100. Serum Institute of India Corporation Information

    Table 101. Serum Institute of India Description and Business Overview

    Table 102. Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)

    Table 103. Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product

    Table 104. Serum Institute of India Recent Developments/Updates

    Table 105. Johnson & Johnson Corporation Information

    Table 106. Johnson & Johnson Description and Business Overview

    Table 107. Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)

    Table 108. Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product

    Table 109. Johnson & Johnson Recent Developments/Updates

    Table 110. Key Raw Materials Lists

    Table 111. Raw Materials Key Suppliers Lists

    Table 112. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Distributors List

    Table 113. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Customers List

    Table 114. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Trends

    Table 115. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Drivers

    Table 116. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Challenges

    Table 117. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Restraints

    Table 118. Research Programs/Design for This Report

    Table 119. Key Data Information from Secondary Sources

    Table 120. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine

    Figure 2. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by Type in 2022 & 2029

    Figure 4. Pediatric Hepatitis B (CHO) Vaccine Product Picture

    Figure 5. Adult Hepatitis B (CHO) Vaccine Product Picture

    Figure 6. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by Application in 2022 & 2029

    Figure 8. Hospitals

    Figure 9. Clinics

    Figure 10. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 11. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size (2018-2029) & (US$ Million)

    Figure 12. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (2018-2029) & (K Doses)

    Figure 13. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Average Price (USD/Dose) & (2018-2029)

    Figure 14. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Report Years Considered

    Figure 15. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Share by Manufacturers in 2022

    Figure 16. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Share by Manufacturers in 2022

    Figure 17. The Global 5 and 10 Largest Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Players: Market Share by Revenue in 2022

    Figure 18. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 19. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 20. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Country (2018-2029)

    Figure 21. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Country (2018-2029)

    Figure 22. U.S. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 23. Canada Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 24. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Country (2018-2029)

    Figure 25. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Country (2018-2029)

    Figure 26. Germany Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 27. France Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 28. U.K. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 29. Italy Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. Russia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Region (2018-2029)

    Figure 32. Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Region (2018-2029)

    Figure 33. China Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 34. Japan Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 35. South Korea Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. Australia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. Taiwan Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. Indonesia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. Thailand Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. Malaysia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Philippines Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Country (2018-2029)

    Figure 44. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Country (2018-2029)

    Figure 45. Mexico Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 46. Brazil Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 47. Argentina Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Country (2018-2029)

    Figure 49. Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Country (2018-2029)

    Figure 50. Turkey Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 51. Saudi Arabia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 52. U.A.E Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. Global Sales Market Share of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by Type (2018-2029)

    Figure 54. Global Revenue Market Share of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by Type (2018-2029)

    Figure 55. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price (USD/Dose) by Type (2018-2029)

    Figure 56. Global Sales Market Share of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by Application (2018-2029)

    Figure 57. Global Revenue Market Share of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by Application (2018-2029)

    Figure 58. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price (USD/Dose) by Application (2018-2029)

    Figure 59. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Value Chain

    Figure 60. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Process

    Figure 61. Channels of Distribution (Direct Vs Distribution)

    Figure 62. Distributors Profiles

    Figure 63. Bottom-up and Top-down Approaches for This Report

    Figure 64. Data Triangulation

    Figure 65. Key Executives Interviewed